AGIO vs MA · rev $65.5M vs P/E 38, rev $17.68B
Agios Pharm (AGIO) versus Mastercard Inc (MA) — a side-by-side from cached financials, not a winner call.
Agios Pharm (AGIO) is a biotechnology company listed on US.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
AGIO currently screens at market cap $1.68B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Not investment advice. Open the AGIO and MA stock pages for the full models.
Not investment advice.